RPG Life Sciences Limited (BOM: 532983)

Market Cap	36.64B
Revenue (ttm)	6.18B
Net Income (ttm)	706.60M
Shares Out	n/a
EPS (ttm)	42.72
PE Ratio	51.85
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	Jun 28, 2024

Volume	133
Open	2,210.20
Previous Close	2,185.60
Day's Range	2,190.00 - 2,227.15
52-Week Range	1,290.30 - 2,976.70
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About RPG Life Sciences

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, and anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and finished dosage formulations for various therapies, which include nephrology, rheumato...

• Industry: Pharmaceutical Preparations
• Founded: 1968
• Employees: 1,270
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 532983

Financial Performance

In 2023, RPG Life Sciences's revenue was 5.82 billion, an increase of 13.50% compared to the previous year's 5.13 billion. Earnings were 876.60 million, an increase of 29.60%.